Related Experiment Videos
[Effect of iodobenzoteph and cytostasan on several immune responses in animals]
Farmakologiia I Toksikologiia
|November 1, 1978
Abstract:
Tests staged on line-bred mice immunized with sheep erythrocytes brought evidence that cystostasan and iodobenzoteph cut down the number of antibody-forming cells both with the primary and secondary immune response. The maximal effect becomes manifest following introduction of the drugs on the 1--2nd day after immunization of the animals. Iodobenzoteph brings down the number of hemopoietic stem cells colonies while cytostosan leaves them unchanged.
Insights
Cystostasan and iodobenzoteph reduce antibody-forming cells during immune responses. Iodobenzoteph also decreases hemopoietic stem cells, while cystostasan does not affect them.
Area of Science:
- Immunology
- Pharmacology
Context:
- Investigating the effects of novel compounds on immune responses.
- Utilizing a mouse model immunized with sheep erythrocytes.
Purpose:
- To evaluate the impact of cystostasan and iodobenzoteph on antibody-forming cells.
- To determine the effect of these drugs on hemopoietic stem cells.
Summary:
- Both cystostasan and iodobenzoteph were found to decrease the number of antibody-forming cells in both primary and secondary immune responses.
- The maximum effect was observed when the drugs were administered 1-2 days post-immunization.
- Iodobenzoteph reduced hemopoietic stem cell colonies, whereas cystostasan did not alter them.
Impact:
- Provides insights into the immunomodulatory effects of cystostasan and iodobenzoteph.
- Highlights differential effects on immune cell populations and stem cells.
- Informs potential therapeutic applications or further research into these compounds.